Advertisement
Screener

FMA ADVISORY INC Historic Quarter Change: Foreign Stocks, Reduced

FMA ADVISORY INC historic quarter change: Foreign Stocks, Reduced

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 6 quarters from 2013-06-30 to 2016-03-31, FMA ADVISORY INC opened 2 positions, added to 13, reduced 8 and sold out of 4.

  • Q4 2014: Stock ULXXXX; Country of operation —; Class SPON ADR NEW; Shares before 51,289.
  • Q3 2014: Stock ULXXXX; Country of operation —; Class SPON ADR NEW; Shares before 55,270.
  • Q1 2014: Stock ULXXXX; Country of operation —; Class SPON ADR NEW; Shares before 55,363.
  • Q1 2014: Stock SNY; Country of operation —; Class SPONSORED ADR; Shares before 28,311.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1298596), 6 quarters: Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-26); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-10-22); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-25); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-06); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-10); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-28). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-06-30. Not compared, as a quarter between them is not held here yet: 2014-12-31 to 2016-03-31 (missing 2015-06-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2014ULXXXX
UNILEVER PLC
SPON ADR NEW51,28951,159-130$2,149,000$2,071,000-$78,0002015-01-26
Q3 2014ULXXXX
UNILEVER PLC
SPON ADR NEW55,27051,289-3,981$2,504,000$2,149,000-$355,0002014-10-22
Q1 2014ULXXXX
UNILEVER PLC
SPON ADR NEW55,36354,922-441$2,281,000$2,350,000+$69,0002014-05-06
Q1 2014SNY
SANOFI
SPONSORED ADR28,31128,194-117$1,518,000$1,474,000-$44,0002014-05-06
Q4 2013TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR14,57711,624-2,953$551,000$466,000-$85,0002014-02-10
Q4 2013SNY
SANOFI
SPONSORED ADR28,55428,311-243$1,446,000$1,518,000+$72,0002014-02-10
Q3 2013TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR17,02714,577-2,450$667,000$551,000-$116,0002013-10-28
Q3 2013SNY
SANOFI
SPONSORED ADR29,52828,554-974$1,521,000$1,446,000-$75,0002013-10-28

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet